Wordt geladen...
Current Status of Immunotherapy for Localized and Locally Advanced Renal Cell Carcinoma
Systemic therapy strategies in the setting of localized and locally advanced renal cell carcinoma (RCC) have continued to evolve in two directions: as adjuvant therapy (to reduce risk of recurrence or progression in high risk localized groups), or as neoadjuvant therapy as a strategy to render prima...
Bewaard in:
| Gepubliceerd in: | J Oncol |
|---|---|
| Hoofdauteurs: | , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Hindawi
2019
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6463563/ https://ncbi.nlm.nih.gov/pubmed/31057615 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2019/7309205 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|